Список проголосовавших за комментарий " Gapping up/down: CWEI +32%. LUX +8% and RAI +4% after M&A news; NFLX +1% after upgrade; TIF -5% after earnings, CMG -1% after downgrade<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>: <strong>EDU</strong> +2.3%, <strong>UNH</strong> +0.5%<br/> <br/> <strong>M&A news</strong>:</p><ul><li><strong>CWEI</strong> +32% ( to be acquired by Noble Energy (NBL) for approx value of $139 per share), <strong>LUX</strong> +8.2% (Essilor and Delfin sign agreement of merger through a combination of Essilor (ESLOY) and Luxottica), <strong>RAI</strong> +4% (British American Tobacco (BTI) to acquire RAI common stock it does not currently own for $59.64 per share)</li></ul><p><strong>Select metals/mining stocks trading higher</strong>: <strong>KGC</strong> +4.8%, <strong>AU</strong> +4.7%, <strong>SBGL</strong> +4.5%, <strong>PAAS</strong> +3.7%, <strong>GG</strong> +3.4%, <strong>ABX</strong> +3.1%, <strong>NEM</strong> +3%, <strong>SLW</strong> +2.8%, <strong>GFI</strong> +1.7%<br/> <br/> <strong>Other news</strong>:</p><ul><li><strong>BVXV</strong> +27.5% (still checking), <strong>BLRX</strong> +8.9% (initiaties a second Phase 2a trial investigating BL-8040 in combination with KEYTRUDA for Pancreatic Cancer), <strong>MUX</strong> +5.5% (reports FY16 production in-line with guidance), <strong>AG</strong> +4.4% (reports 2016 production +16%), <strong>IAG</strong> +4.3% (reports Q4 production above guidance), <strong>HMY</strong> +3.2% (reports H1 gold production rose 8% YoY), <strong>RIO</strong> +1.8% (reports Q4 production; iron ore shipments in-line with guidance)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>LAMR</strong> +1.1% (upgraded to Buy from Neutral at Goldman), <strong>NFLX</strong> +1% (upgraded to Buy from Neutral at Mizuho), <strong>AXP</strong> +0.6% (upgraded to Overweight from Neutral at JP Morgan), <strong>DIS</strong> +0.5% (upgraded to Buy from Neutral at Goldman)</li></ul><p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>CBK</strong> -16.2%, <strong>TIF</strong> -4.7%, <strong>PLG</strong> -3.9%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>NBL</strong> -0.5% (to acquire CWEI for $139 per share)</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>ADHD</strong> -52.6% (reports that the Phase 3 clinical trial of MDX in adults with ADHD missed the primary endpoint)</li><li><strong>GLBS</strong> -26.1% (announced that its previously disclosed private placement/conversion of debt will not occur as planned (previously described on November 28, 2016))</li><li><strong>UEC</strong> -11.9% (confirms underwritten public offering of units of the company at price of $1.50/unit)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>VOD</strong> -2.7% (downgraded to Hold from Buy at HSBC)</li><li><strong>NVS</strong> -1.6% (downgraded to Hold from Buy at Berenberg)</li><li>C<strong>MG</strong> -1.4% (downgraded to Neutral from Overweight at JP Morgan)</li><li><strong>TWTR</strong> -1.1% (downgraded to Neutral from Buy at UBS)</li><li><strong>NAVI</strong> -1.1% (downgraded to Neutral from Overweight at JP Morgan )</li><li><strong>ING</strong> -1% (downgraded to Neutral from Buy at Goldman)</li></ul>"